BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 22093482)

  • 1. Estrogen receptor dependent gene expression by osteoblasts - direct, indirect, circumspect, and speculative effects.
    Centrella M; McCarthy TL
    Steroids; 2012 Feb; 77(3):174-84. PubMed ID: 22093482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells.
    Cao L; Bu R; Oakley JI; Kalla SE; Blair HC
    J Cell Biochem; 2003 May; 89(1):152-64. PubMed ID: 12682916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between CCAAT enhancer binding protein delta and estrogen receptor alpha control insulin-like growth factor I (igf1) and estrogen receptor-dependent gene expression in osteoblasts.
    Chang W; Parra M; Centrella M; McCarthy TL
    Gene; 2005 Jan; 345(2):225-35. PubMed ID: 15716114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin dependent control of an endogenous estrogen receptor agonist by osteoblasts.
    McCarthy TL; Centrella M
    J Cell Physiol; 2015 May; 230(5):1104-14. PubMed ID: 25292157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogen on collagen synthesis by cultured human osteoblasts depend on the rate of cellular differentiation.
    Ireland DC; Bord S; Beavan SR; Compston JE
    J Cell Biochem; 2002; 86(2):251-7. PubMed ID: 12111994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblastic differentiation induced by transcription factor decoy against estrogen receptor alpha gene.
    Lambertini E; Penolazzi L; Aguiari G; del Senno L; Pezzetti F; Sollazzo V; Piva R
    Biochem Biophys Res Commun; 2002 Apr; 292(3):761-70. PubMed ID: 11922631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
    Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis.
    Dang Z; Löwik CW
    J Bone Miner Res; 2004 May; 19(5):853-61. PubMed ID: 15068509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dexamethasone, ascorbic acid, and β-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression.
    Park JB
    J Surg Res; 2012 Mar; 173(1):99-104. PubMed ID: 21035140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated aromatase expression in osteoblasts leads to increased bone mass without systemic adverse effects.
    Sjögren K; Lagerquist M; Moverare-Skrtic S; Andersson N; Windahl SH; Swanson C; Mohan S; Poutanen M; Ohlsson C
    J Bone Miner Res; 2009 Jul; 24(7):1263-70. PubMed ID: 19257817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
    Ishibashi O; Yamagishi T; Hanada K; Kawashima H
    Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
    Dutertre M; Smith CL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the human oestrogen receptor-alpha gene is regulated by promoter F in MG-63 osteoblastic cells.
    Lambertini E; Penolazzi L; Giordano S; Del Senno L; Piva R
    Biochem J; 2003 Jun; 372(Pt 3):831-9. PubMed ID: 12659635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive exposure to TGF-beta suppresses TGF-beta type I receptor expression by differentiated osteoblasts.
    Kim KK; Ji C; Chang W; Wells RG; Gundberg CM; McCarthy TL; Centrella M
    Gene; 2006 Sep; 379():175-84. PubMed ID: 16806744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene.
    Huo B; Dossing DA; Dimuzio MT
    J Bone Miner Res; 1995 May; 10(5):769-81. PubMed ID: 7639112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on estrogen receptor of adult human osteoblasts].
    Ouyang GL; Yang QM; Deng LF; Xu FP; Zhu YP
    Zhong Xi Yi Jie He Xue Bao; 2003 Jul; 1(2):132-4. PubMed ID: 15339587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogenic bias in T-Lymphocyte biology: Implications for cardiovascular disease.
    Rosenzweig R; Gupta S; Kumar V; Gumina RJ; Bansal SS
    Pharmacol Res; 2021 Aug; 170():105606. PubMed ID: 34119620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.